Recorded at the 2025 American Heart Association Scientific Sessions, hosts Manesh Patel and Emily O'Brien discuss late-breaking cardiovascular research, including gene-editing therapy for cholesterol, AFib management strategies, and, for coffee lovers, the DECAF trial's findings on caffeine and heart rhythm.
#AHA25 #beyondtheendpoint #cardiology #podcast #hearthealth #clinicalresearch
All content for Beyond the Endpoint is the property of Duke Clinical Research Institute and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Recorded at the 2025 American Heart Association Scientific Sessions, hosts Manesh Patel and Emily O'Brien discuss late-breaking cardiovascular research, including gene-editing therapy for cholesterol, AFib management strategies, and, for coffee lovers, the DECAF trial's findings on caffeine and heart rhythm.
#AHA25 #beyondtheendpoint #cardiology #podcast #hearthealth #clinicalresearch
Connecting the Dots: The Broader Applications of GLP-1s and Where We’re Headed Next
Beyond the Endpoint
36 minutes 41 seconds
3 weeks ago
Connecting the Dots: The Broader Applications of GLP-1s and Where We’re Headed Next
Endocrinologist Jennifer Green discusses how GLP-1 drugs, like Ozempic, evolved from diabetes tools to potential treatments for addiction and heart disease, in this final installment of the obesity series. The discussion also touches on critical questions about long-term use, access, and emerging innovations.
Beyond the Endpoint
Recorded at the 2025 American Heart Association Scientific Sessions, hosts Manesh Patel and Emily O'Brien discuss late-breaking cardiovascular research, including gene-editing therapy for cholesterol, AFib management strategies, and, for coffee lovers, the DECAF trial's findings on caffeine and heart rhythm.
#AHA25 #beyondtheendpoint #cardiology #podcast #hearthealth #clinicalresearch
